• ECALLANTIDE CHEMBL1201837 FDA Approved

    Alternate Names:

    Ecallantide
    DX-88
    750596-66-8
    460738-38-9
    (GLU20,ALA21,ARG36,ALA30,HIS39,PRO40,TRP42)TISSUE FACTOR PATHWAY INHIBITOR (HUMAN)-(20-79)-PEPTIDE (MODIFIED ON REACTIVE BOND REGION KUNITZ INHIBITOR1 DOMAIN CONTAINING FRAGMENT)
    PROTEIN (SYNTHETIC HUMAN PLASMA KALLIKREIN-INHIBITING)
    HUMAN PLASMA KALLIKREIN?INHIBITOR (SYNTHETIC PROTEIN)
    DX 88
    FOV2302
    DX88
    5Q6TZN2HNM
    ECALLANTIDE [USAN:INN]
    UNII-5Q6TZN2HNM
    BITOR
    44152182
    KALBITOR
    47205919
    DCL000108
    DB05311

    Drug Info:

    Drug Class treatment for hereditary angiooedema
    Year of Approval 2009
    FDA Approval 2009
    Drug Class peptide
    Drug Indications Treatment for Hereditary Angiooedema
    Drug Categories kallikreins, antagonists & inhibitors
    Drug Categories drugs used in hereditary angioedema
    Drug Categories blood and blood forming organs
    Drug Categories amino acids, peptides, and proteins
    Drug Groups approved
    Drug Type small molecule
    (2 More Sources)